Publication | Closed Access

Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants

Transplant RejectionOkt3 Monoclonal AntibodyTransplantationAnti-thymocyte GlobulinKidney TransplantKidney TransplantationPediatric Renal TransplantsHematologyImmunologyAutoimmunityGraft SurvivalImmunotherapyMedicineNephrologyGraft Rejection